Nvidia CEO Makes First Ever Tesla Announcement

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

ALNY
Alnylam Pharmaceuticals Inc
NASDAQ
465.63
Open 462.60 Prev Close 464.95
High 466.40 Low 462.60
Volume 198 Volume (Avg) 1,154
52 Week High 484.21 52 Week Low 205.87
Market Cap 61B PE Ratio

Shares Stats

Shares Outstanding130,980,000
Shares Float125,500,000
Shares Short3,510,000
Insider Holdings382%
Institution Holdings99.27%

About Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

General

NameAlnylam Pharmaceuticals Inc
TickerALNY
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees2,230

Highlights

Analyst Target473.96
Market Cap61,034,300,000
PEG Ratio-0.49
EBITDA-123,687,000

Financials

Curr Year EPS Estimate4.07
Next Quarter EPS Estimate0.54
Profit Margin-12.96%
Operating Margin-7.32
Return on Assets-0.03
Return on Equity-2.58
Revenue2.5B
Earnings Per Share-2.46
Revenue Per Share19.01
Gross Profit2,059,246,976
Quarterly Revenue Growth0.17

Valuation

Forward PE46.51
Price/Sales (Trailing 12 Mt.)24.75
Price/Book (Most Recent Quarter)241.13

Earnings

Most Popular

Kitchen cabinet companies hope new US tariffs pay off in the long run

NEW YORK (AP) — Cabinet dealers, interior designers and remodeling contractors in the U.S. hope on imported kitchen cabinets, bathroom vanities and upholstered wooden furniture that kicked in Tuesday will create more business for them and eventually boost domestic production of those products.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

China sanctions 5 US units of South Korean shipbuilder Hanwha Ocean over probe by Washington

HONG KONG (AP) — China’s Commerce Ministry said Tuesday it was banning dealings by Chinese companies with five subsidiaries of South Korean shipbuilder Hanwha Ocean in the latest swipe by Beijing at U.S. President Donald Trump's effort to rebuild the industry in America.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Billionaire Makes $72 Million On Trilogy Metals Stock—Here's What Else He's Holding

Billionaire hedge fund manager John Paulson has scored extraordinary gains with Trilogy Metals—he's also holding gold miners.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Senate confirmation of Trump nominee cements his shake-up of top civil rights agency

The Senate confirmed President Donald Trump's pick to fill a critical vacancy at the top agency for worker rights, restoring it to the full power needed to deepen his overhaul of civil rights enforcement.

Why Is Wall Street Moving Their Money Overnight? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Claim Your Share of $5.39 Billion in AI Equity Checks - Ad

Virtually every AI model is built off stolen data...so it's only fair that you deserve some kind of compensation...And the U.S. government seems to agree. Which is why you could now receive as much as $3,452.50 per month on average from "AI Equity Checks."

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Asian shares tumble after Trump says he will impose new tariffs on drugs and other goods

MANILA, Philippines (AP) — Asian shares fell on Friday after President Donald Trump announced plans for new tariffs including starting Oct. 1.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

A drug made from marijuana reduced back pain in a large study

WASHINGTON (AP) — An experimental medication made from successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of .

Stocks Ease, Delta Air Lines, Pepsi Jump On Strong Earnings: What's Moving Markets Thursday?

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open.

October 16: D-Day For The Dollar - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44. The company's market cap stands at $156.6 million.

Western Digital Stock Rises As Analyst Sees Upside Ahead

Shares of Western Digital Corporation (NASDAQ: WDC) are up Monday following positive analyst coverage from Rosenblatt. Here’s what you need to know.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Tesla offers cheaper version of its best-selling EV in bid to win back market share in a tough year

NEW YORK (AP) — Tesla announced the rollout of a new, cheaper version of its best-selling electric car on Tuesday in hopes the offering will help revive flagging sales.

How To Earn $500 A Month From JPMorgan Stock Ahead Of Q3 Earnings

JPMorgan (NYSE:JPM) will release Q3 earnings on Oct. 14. Analysts expect $4.86 EPS and $45.42B revenue. Dividend yield currently at 1.96%.

Nvidia CEO Makes First Ever Tesla Announcement - Ad

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

The Big Mac That Cost $380,000: Why The Early Bitcoin Believer Who Paid 3.5 BTC For The Burger Has Zero Regrets

The story about the purchase of Papa John’s pizzas using Bitcoin (CRYPTO: BTC) is legendary, but did you know that someone also once paid for a Big Mac with the world’s largest cryptocurrency

23 miners rescued after 43 hours trapped in Colombian gold mine

BOGOTA, Colombia (AP) — Twenty-three workers were rescued Wednesday after spending 43 hours trapped in a in northern Colombia. The miners were met with applause as they emerged from the La Reliquia mine, located in the Antioquia department.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Penguin Solutions Q4 Preview: Modest Beat Likely, Analyst Raises Price Target

Penguin Solutions expected to beat estimates in Q4 due to strong memory demand, according to Rosenblatt analyst. Price target raised.

Verizon, GE Vernova Launch Wireless Platform To Help Modernize America's Grid (CORRECTED)

Verizon and GE Vernova collaborate to modernize the power grid with MDS Orbit, providing secure wireless infrastructure to support critical operations.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chro

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service